Are you a robotics manufacturer?
Claim your page to correct your specs and keep your listing current.
DePuy Synthes is a robotics company founded 1886, based in United States, developing 1 robot primarily in the Surgical / Medical category.
CAPITAL & EVIDENCE
DePuy Synthes has no confirmed funding round on file and has 1 known customer, not yet tied to a specific model.
Shipped
1 known customer — no deployment yet tied to a specific model
Used by
Named in a public source that did not say which model
- Department of Veterans Affairs· United Statesusaspending.gov
Innovative orthopaedics and medtech for knee replacement surgery
VELYS™ Robotic-Assisted Solution is a robotic knee-surgery platform made by Johnson & Johnson MedTech’s DePuy Synthes subsidiary. It is an imageless, bed-mounted system for total knee arthroplasty, designed to work with the ATTUNE Total Knee System and later expanded to unicompartmental knee arthroplasty. Johnson & Johnson is headquartered in New Brunswick, New Jersey, and operates globally through its medtech businesses.
Active products
1
RoboIndex
51.39
RoboScore 51.39 + Momentum 0.00
Company facts
- HQ
- New Brunswick, United States
- Founded
- 1886 · 140 yrs
- Website
- www.jnj.com
RoboScore
51.39 RoboScore + 0.00 Momentum· Adequate evidence
Products 65%, Depth 5%, Evidence 30% set the number, and every rated company has all three. Attention has no weight of its own — it is one of the two things Evidence is built from, and it can only ever add. Activity and Readiness describe the brand but never move it. A value we don't have reads —, never zero. Momentum is independently collected news coverage, worth at most 15 points and never a deduction — a maker we have heard nothing about keeps its full RoboScore. Claiming or paying moves nothing.
6 of 6 factors known. How it's calculated
Milestones
Johnson & Johnson MedTech announced FDA clearance to expand VELYS Robotic-Assisted Solution for unicompartmental knee arthroplasty procedures.
DePuy Synthes received 510(k) FDA clearance for VELYS Robotic-Assisted Solution for use with the ATTUNE Total Knee System.
Press coverage
- DePuy Synthes Receives 510(k) FDA Clearance for VELYS Robotic-Assisted Solution Designed for Use with the ATTUNE Total Knee System
Johnson & Johnson · Jan 2021
- DePuy Synthes Receives 510(k) FDA Clearance of the VELYS Robotic-Assisted Solution for Use in Unicompartmental Knee Arthroplasty Procedures
PR Newswire · May 2024
Public loss record
FDA
US makers file into registers that compel reporting — device adverse events to the FDA, driverless crashes to NHTSA, workplace deaths to OSHA. A maker with no record here has genuinely not had one filed against it.
A filing records that someone reported something. It is not a finding that the robot caused it, and we make no such finding.
Active products by DePuy Synthes
1 shown| # | Category | Key specs | ||||
|---|---|---|---|---|---|---|
| 1 | VELYS™ Robotic-Assisted Solution | Surgical / Medical | DOF 3 DOF | 2021 | 56.4 |
Surgical / Medical buying guides
Industry Knowledge →
Surgical Robot Vendor Selection: Support Coverage, Software Upgrades, and Lifecycle
A surgical robot purchased today will be in your OR for 10–15 years. The support SLA, software upgrade path, end-of-life timeline, and field service model deter…
Pilot to Scale: Case Volume Thresholds for Surgical Robot ROI
Most surgical robot programs break even somewhere between 150 and 400 cases per year depending on platform, procedure mix, and reimbursement. The math is knowab…
Surgeon Training Curve and Proctoring: The 18-Month Onboarding Window
A surgeon's robotic learning curve runs 20–150 cases depending on procedure and prior experience. The proctoring structure, credentialing ladder, and OR efficie…